MP21-10 A URINARY PROTEOMICS ANALYSIS OF PATIENTS TREATED WITH NEOADJUVANT AXITINIB FOR NON-METASTATIC CLEAR-CELL RENAL-CELL CARCINOMA: ANALYSIS FROM A PHASE II TRIAL

Andrew McIntosh,Hong Wang,Eric Umbreit,Chalairat Suk-Ouichai,Graciela Nogueras Gonzalez,Justin T. Matulay,Christopher G. Wood,Samir Hanash,Jose Antonio Karam

MP21-10 A URINARY PROTEOMICS ANALYSIS OF PATIENTS TREATED WITH NEOADJUVANT AXITINIB FOR NON-METASTATIC CLEAR-CELL RENAL-CELL CARCINOMA: ANALYSIS FROM A PHASE II TRIAL

2019

Andrew McIntosh
Hong Wang
Eric Umbreit
Chalairat Suk-Ouichai
Graciela Nogueras Gonzalez
Justin T. Matulay
Christopher G. Wood
Samir Hanash
Jose Antonio Karam

INTRODUCTION AND OBJECTIVES:In-depth mass-spectrometry profiling of biological fluids offers an opportunity to identify novel cancer biomarkers. Urine proteome analysis has the potential to discove...

Keywords:

Urology
Axitinib
Urinary system
Clear cell renal cell carcinoma
Proteomics
Medicine
Oncology
Cancer biomarkers
Pathology
Proteome
Urine
Internal medicine
non metastatic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations